KPIs & Operating Metrics(New)
Balance Sheet
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInventory AverageInvested Capital

Novartis Ag (NVS) Assets Average (2018 - 2025)

Novartis Ag's Assets Average history spans 8 years, with the latest figure at $106.6 billion for Q4 2025.

  • For Q4 2025, Assets Average rose 5.44% year-over-year to $106.6 billion; the TTM value through Dec 2025 reached $106.6 billion, up 5.44%, while the annual FY2025 figure was $106.6 billion, 5.44% up from the prior year.
  • Assets Average for Q4 2025 was $106.6 billion at Novartis Ag, up from $101.1 billion in the prior quarter.
  • Across five years, Assets Average topped out at $129.8 billion in Q4 2021 and bottomed at $101.1 billion in Q4 2024.
  • The 5-year median for Assets Average is $108.7 billion (2023), against an average of $114.2 billion.
  • The largest annual shift saw Assets Average increased 5.45% in 2021 before it decreased 12.78% in 2023.
  • A 5-year view of Assets Average shows it stood at $129.8 billion in 2021, then decreased by 3.98% to $124.6 billion in 2022, then decreased by 12.78% to $108.7 billion in 2023, then fell by 7.0% to $101.1 billion in 2024, then rose by 5.44% to $106.6 billion in 2025.
  • Per Business Quant, the three most recent readings for NVS's Assets Average are $106.6 billion (Q4 2025), $101.1 billion (Q4 2024), and $108.7 billion (Q4 2023).